PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of annaldermaThis ArticleThis JournalAboutInformation for AuthorsOnline SubmissionAnnals of Dermatology
 
Ann Dermatol. 2009 November; 21(4): 396–398.
Published online 2009 November 30. doi:  10.5021/ad.2009.21.4.396
PMCID: PMC2861272

Neurocristic Cutaneous Hamartoma of the Scalp

Sue Kyung Kim, M.D. and You Chan Kim, M.D.corresponding author

Abstract

Neurocristic cutaneous hamartomas (NCHs) result from aberrant development of the neuromesenchyme. In addition to a dermal melanocytic component, these tumors can contain neuro sustentacular and fibrogenic components. The clinical importance of these lesions includes the potential for misdiagnosis as well as the development of malignant melanomas over a poorly described period of time. We present a rare case of NCH of the scalp in a 1-year-old female.

Keywords: Hamartoma, Neurocristic, Scalp

INTRODUCTION

Neurocristic hamartomas (NCH) result from the aberrant development of cells derived from the neural crest. This abnormality was first described by Tuthill et al.1 in 1982 and referred to as a pilar neurocristic hamartoma1-3. Neural crest-derived cells show fibrogenic, melanogenic, and neurosustentacular differentiation, and contribute to the formation and development of the local mesenchyme, especially in the cephalic regions3. The importance of the recognition of a NCH is due to the possible transformation to a malignant melanoma of the pigmented lesions over an unpredictable period of time4. We report a patient that presented with a blue-gray alopecic plaque on the scalp with the histopathological features of a NCH.

CASE REPORT

A 1-year-old female presented with an asymptomatic alopecic plaque that was present since birth on the scalp. Physical examination showed a 3×2 cm blue-gray plaque on the scalp with focal alopecia (Fig. 1). We initially suspected a blue nevus and performed a skin biopsy. The biopsy specimen revealed proliferation of nerve-like structures, spindle cells, and melanocytes. High power microscopic views showed fascicles of spindled cells and heavily pigmented cells with dendritic morphology (Fig. 2).

Fig. 1
3×2 cm blue-gray plaque on the scalp.
Fig. 2
(A) Proliferation of nerve-like structures, spindle cells, and melanocytes (H&E, ×100) (inset, wavy spindle cells, ×400). (B) Diffuse S-100 protein staining within the nerve-like structures and pigmented cells (Immunohistochemical ...

Immunohistochemical staining showed diffuse S-100 protein staining within nerve-like structures and pigmented cells that extended to the deep dermis. HMB-45 also diffusely stained the pigmented cells; however, the area with schwannian differentiation did not stain with HMB-45. The stromal cells throughout the lesion were diffusely stained with CD34. NSE stained within the nerve-like structures. Magnetic resonance imaging showed a focal enhancing lesion in the deep soft tissue of the scalp.

However, there was no evidence of abnormalities in the cortex of the brain. Because the patient was too young at the time of the initial evaluation surgical excision was planned for later.

DISCUSSION

Several cases of NCHs have been reported previously1,2,4-11. In the Korean dermatologic literature, a case of dermal melanocytosis on the trunk with features of neurocristic cutaneous hamartoma has been reported12. The dermal melanocytoses include a variety of pigmented lesions that are formed from the aberrant development of neural crest-derived melanocytes as they migrate through the dermis during embryogenesis5. NCH is one type of dermal melanocytosis. NCH is composed of melanocytes that are confined to the dermis and sometimes the subcutaneous tissue with a neural crest-derived Schwann cell component5. Clinically and histopathologically, the features of NCHs overlap with other dermal melanocytoses, especially the blue nevus. The clinical features in this case resembled the plaque-type blue nevus. However, NCHs have a predilection for the scalp with focal alopecia and generally are not found on the trunk. Histologically, NCH lesions are composed of dermal melanocytes and neuroidal structures with schwannian differentiation. NCH lesions usually stain with CD34 and have a decreased number of hair follicles5. However, blue nevus lesions usually are not stained with CD34 and the number of hair follicles with a blue nevus are not decreased9. Other reported features of NCH include melanocytes distributed around hair follicles, eccrine glands, vessels and nerves, involvement of the subcutaneous tissue, and the presence of tactoid bodies1,2,9-11. In our case, we also noted proliferation of dermal melanocytes and neuroidal structures with schwannian differentiation. The immunohistochemical staining with S-100 protein, HMB-45, CD34, and NSE confirmed the diagnosis.

Although only a few cases have been reported, a significant number of these cases have shown development of a malignant melanocytic component2,10. Melanomas have developed within 1~6 years from the initial diagnosis of NCH. However, melanomas developing from congenital NCH lesions have been identified 15~67 years after birth2. Because of the unpredictable development of a malignancy, long-term follow up with cancer surveillance is generally recommended in patients with NCH2,13. Complete surgical resection of the lesion likely prevents the development of a melanoma.

In summary, we describe a rare case of NCH of the scalp with alopecia. Dermatologists should consider NCH in the differential diagnosis of a blue-gray alopecic plaque on the scalp. Early diagnosis is useful for the proper management of NCH including surveillance for the development of a malignant melanoma.

References

1. Tuthill RJ, Clark WH, Jr, Levene A. Pilar neurocristic hamartoma: its relationship to blue nevus and equine melanotic disease. Arch Dermatol. 1982;118:592–596. [PubMed]
2. Pearson JP, Weiss SW, Headington JT. Cutaneous malignant melanotic neurocristic tumors arising in neurocristic hamartomas. A melanocytic tumor morphologically and biologically distinct from common melanoma. Am J Surg Pathol. 1996;20:665–677. [PubMed]
3. Reed RJ. Neuromesenchyme. The concept of a neurocristic effector cell for dermal mesenchyme. Am J Dermatopathol. 1983;5:385–395. [PubMed]
4. Denlinger CE, Slingluff CL, Jr, Mihm MC, Jr, Patterson JW. Extensive neurocristic hamartoma with skeletal muscle involvement. J Cutan Pathol. 2007;34:634–639. [PubMed]
5. Bevona C, Tannous Z, Tsao H. Dermal melanocytic proliferation with features of a plaque-type blue nevus and neurocristic hamartoma. J Am Acad Dermatol. 2003;49:924–929. [PubMed]
6. Crowson AN, Magro CH, Clark WH. Pilar neurocristic hamartoma. J Am Acad Dermatol. 1996;34:715. [PubMed]
7. Karamitopoulou-Diamantis E, Paredes B, Vajtai I. Cutaneous neurocristic hamartoma with blue naevus-like features and plexiform dermal hyperneury. Histopathology. 2006;49:326–328. [PubMed]
8. Kikuchi I, Inoue S, Taketomi I, Ono T. Two cases of nevus fuscocaeruleus with pain, including a case of pilar neurocristic hamartoma. J Dermatol. 1983;10:275–280. [PubMed]
9. Mezebish D, Smith K, Williams J, Menon P, Crittenden J, Skelton H. Neurocristic cutaneous hamartoma: a distinctive dermal melanocytosis with an unknown malignant potential. Mod Pathol. 1998;11:573–578. [PubMed]
10. Pathy AL, Helm TN, Elston D, Bergfeld WF, Tuthill RJ. Malignant melanoma arising in a blue nevus with features of pilar neurocristic hamartoma. J Cutan Pathol. 1993;20:459–464. [PubMed]
11. Smith KJ, Mezebish D, Williams J, Elgart ML, Skelton HG. The spectrum of neurocristic cutaneous hamartoma: clinicopathologic and immunohistochemical study of three cases. Ann Diagn Pathol. 1998;2:213–223. [PubMed]
12. Jin WW, Jung KE, Park JW, Kim MH. A case of dermal melanocytosis with features of neurocristic cutaneous hamartoma. Korean J Dermatol. 2008;46:1245–1248.
13. Goldenhersh MA, Savin RC, Barnhill RL, Stenn KS. Malignant blue nevus. Case report and literature review. J Am Acad Dermatol. 1988;19:712–722. [PubMed]

Articles from Annals of Dermatology are provided here courtesy of Korean Dermatological Association and Korean Society for Investigative Dermatology